Qingqing H. Zhang

Department Of Tumor And Immunology In Precision Medical Institute And Western China Science And Technology Innovation Port
Xi'an, 710004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Development and Mechanistic Evaluation of Cathepsin B-Activatable Peptide-Drug Conjugate PROTACs for Targeted Protein Degradation in Malignant Tumors: Advancing Precision Protein Degradation Therapeutics in Oncology.

Development and Mechanistic Evaluation of Cathepsin B-Activatable Peptide-Drug Conjugate PROTACs for Targeted Protein Degradation in Malignant Tumors: Advancing Precision Protein Degradation Therapeutics in Oncology.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: May 31, 2025

Syringin ameliorates dextran sulphate colitis via alteration oxidative stress, inflammation NF-κB signalling pathway and gut microbiota.

Syringin ameliorates dextran sulphate colitis via alteration oxidative stress, inflammation NF-κB signalling pathway and gut microbiota.

Journal: Basic & clinical pharmacology & toxicology

Published: August 21, 2024

Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool.

Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool.

Journal: Bioorganic chemistry

Published: January 08, 2024

Novel multi-target angiogenesis inhibitors as potential anticancer agents: Design, synthesis and preliminary activity evaluation.

Novel multi-target angiogenesis inhibitors as potential anticancer agents: Design, synthesis and preliminary activity evaluation.

Journal: Bioorganic chemistry

Published: December 13, 2023

Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library.

Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library.

Journal: International journal of molecular sciences

Published: May 24, 2023

Discovery of novel PROTACs based on multi-targeted angiogenesis inhibitors.

Discovery of novel PROTACs based on multi-targeted angiogenesis inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: February 11, 2023

Discovery of novel protein degraders based on bioorthogonal reaction-driven intracellular self-assembly strategy.

Discovery of novel protein degraders based on bioorthogonal reaction-driven intracellular self-assembly strategy.

Journal: Bioorganic chemistry

Published: February 06, 2023

Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction.

Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction.

Journal: European journal of medicinal chemistry

Published: February 06, 2023

The Recent Advance of Cell-Penetrating and Tumor-Targeting Peptides as Drug Delivery Systems Based on Tumor Microenvironment.

The Recent Advance of Cell-Penetrating and Tumor-Targeting Peptides as Drug Delivery Systems Based on Tumor Microenvironment.

Journal: Molecular pharmaceutics

Published: January 04, 2023

Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance.

Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance.

Journal: Pharmacology & therapeutics

Published: December 31, 2022

Design, synthesis and bioactivity evaluation of self-assembled PROTACs based on multi-target kinase inhibitors.

Design, synthesis and bioactivity evaluation of self-assembled PROTACs based on multi-target kinase inhibitors.

Journal: Bioorganic chemistry

Published: December 22, 2022

Discovery of novel antibody-drug conjugates bearing tissue protease specific linker with both anti-angiogenic and strong cytotoxic effects.

Discovery of novel antibody-drug conjugates bearing tissue protease specific linker with both anti-angiogenic and strong cytotoxic effects.

Journal: Bioorganic chemistry

Published: December 18, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026